RA Capital Nexus Fund II, Director: Werewolf Therapeutics HOWL Buy · Filed 25/05/14

Trade details

Type: Insider buy
Amount: $275,985.18
Shares · price: 320,913 sh · $0.86 a share
Held after: 6,021,969 sh
Stock: Werewolf Therapeutics HOWL
Person: RA Capital Nexus Fund IIDirector
Trade date: 25/05/12
Filed: 25/05/14
Days to filing: 2 days

First buy since 2023

Insiders buying this week: 5 insiders
Holding change: +5.6%

Werewolf Therapeutics trades, last 26 weeks

What else happened in Werewolf Therapeutics around then

Filed or reported within 30 days of the trade day · 25/04/12~25/06/11

RA Capital Nexus Fund II's recent trades

RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$45.7M
2,541,250 sh
$45.7M
Filed 05/06
Traded 05/04
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$2.4M
133,750 sh
$2.4M
Filed 05/06
Traded 05/04
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$2.1M
87,143 sh
$2.1M
Filed 05/06
Traded 05/05
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$1.3M
53,407 sh
$1.3M
Filed 05/06
Traded 05/06
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$347.3K
14,611 sh
$347.3K
Filed 05/06
Traded 05/06

RA Capital Nexus Fund II, Director — bought $276K of Werewolf Therapeutics HOWL · 320,913 sh @ $0.86 | Whalegun